Uncategorized
These Analysts Revise Their Forecasts On Chewy Following Q1 Results
Latest Ratings for CHWY Date Firm Action From To Mar 2022 Deutsche Bank Initiates Coverage On Buy Jan 2022 RBC Capital Initiates Coverage On Outperform Jan 2022 Piper Sandler Downgrades Overweight Neutral View More Analyst Ratings for CHWY View the Latest Analyst Ratings read more
Biogen, UCB Take A Leap In Lupus With Promising Phase 3 Results
UCB and Biogen’s lupus candidate showed strong Phase 3 results, including fatigue improvement and higher remission versus standard care. read more
Houston American Energy (HUSA) Stock Soars Over 27%: What’s Going On?
Houston American Energy shares are soaring Thursday as Middle East tensions drove crude oil prices higher. High trading volume and significant short interest are likely fueling the move higher. read more
Papa John’s Takeover Rumors Swirl, But Doubts Are Creeping In
Papa John’s shares dip after Wednesday’s buyout buzz fades, despite reports of a $2B bid from Apollo and Irth Capital. read more
BlackRock Targets $280 Billion Market Cap, $35 Billion Revenue By 2030
BlackRock Inc outlines plan to raise $400B in alternative assets by 2030 and increase total revenue from $20B to over $35B. Private markets to contribute 30% of revenue by 2030. read more
Tonix Pharmaceuticals (TNXP) Files To Raise $500 Million, Shares Tumble
Tonix Pharmaceuticals has filed a registration statement to sell up to $500 million in securities. The company’s lead drug candidate is for the management of fibromyalgia pain. read more
